1REGN:BIT
Regeneron Pharmaceuticals Inc
€659.80
arrow_upward
+1.15%(+7.50) 1D
Oct 2, 5:26:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1REGN...
Open
€659.80
High
€659.80
Low
€659.80
Mkt. cap
76.86B
Avg. vol.
4.00
Volume
1.00
52-wk high
€724.70
52-wk low
€467.50
No. of employees
15K
Open
€659.80
High
€659.80
Low
€659.80
Mkt. cap
76.86B
Avg. vol.
4.00
Volume
1.00
52-wk high
€724.70
52-wk low
€467.50
No. of employees
15K
News stories
From web sources and news partners
AD HOC NEWS
·
8 hours ago
Regeneron stock trades 0.24 percent above its EUR 664.95 Xetra close
AD HOC NEWS
·
1 day ago
Morgan Stanley raises target for Regeneron stock to USD 779
Trefis
·
1 day ago
What Is Going On With Regeneron Stock?
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com